Pharm Sector In Laos
Upcoming SlideShare
Loading in...5
×
 

Pharm Sector In Laos

on

  • 1,965 views

Conference on Health and Social Protection: Meeting the needs of the poor, 09-10 October 2008

Conference on Health and Social Protection: Meeting the needs of the poor, 09-10 October 2008
www.povill.com

Statistics

Views

Total Views
1,965
Views on SlideShare
1,964
Embed Views
1

Actions

Likes
0
Downloads
25
Comments
0

1 Embed 1

http://www.slideshare.net 1

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharm Sector In Laos Pharm Sector In Laos Presentation Transcript

  • Strategies for improving Pharmaceutical Use - The Role of Drug Regulatory Agency in Lao PDR Conference on Health and Social Protection Meeting the Needs of the Poor 09-10 October 2008, Lane Xang Hotel By Lamphone Syhakhang Head of drug Control Division, Food and Drug Department, Ministry of Health Lao PDR
  • Outline of presentation
    • 1. Drug Regulatory Authority at different levels
    • 2. Main Role of Drug Regulatory Authority
    • 3. Important Regulatory instruments
    • 4. Challenges
    • 5. Lessons learned/ suggestions
  • 1. Drug Regulatory Authorities at different levels
    • Central level: Food and Drug Department (FDD)
    • Province level: Provincial Food and Drug Unit
    • District level: District Food and Drug Unit
    • + Food and Drug committee at each level
    • + Cooperation with Customs, Police, Trade, Justice and Local Governments
  • 2. Main Role of Drug Regulatory Authorities
    • Ensuring quality and use of medicines
    • Pre-marketing quality assessment:
    • marketing authorization, licensing and registration
    • Post-marketing surveillance:
    • quality and adverse events, advertising, and promotion control
    • Adequate legislation and law enforcement
  • 3. Important Regulatory Instruments
    • National Medicine Policy
    • Law and Regulations
      • Registration and licensing system
      • including stamps for imported and
      • registered drugs
    • Drug selection and
      • nomenclature
      • - National Essential Medicine List
    • System for drug
      • procurement
  • 3. Important Regulatory Instruments (con’t)
    • Quality Assurance System
    • Monitoring system for pharmacies, companies and factories through GPP, GWP and GMP indicators, drug sampling and analysis
    • Sanctions and punishments
  • 3. Important Regulatory Instruments (con’t)
    • Promotion of RUD :
    • IEC to Health providers and general public through different media means
    • Monitoring the use of medicines in hospitals through STG and RUD indicators
    • Drug Therapeutic Committees at all provincial hospitals.
  • 4. Challenges
    • Enforcement of law and regulations
      • Availability of substandard, counterfeit
      • Strict sanctions and punishment
    • Strengthening the drug QA system
    • Improve RUD through IEC and training
    • Effective management and financial systems
    • Limitations of human resources in terms of skilled personnels
  • 5. Lessons learned
    • 1. Increase enforcement of law and regulations
    • 2. Strong Cooperation with relevant organisations e.g., Police, customs, Trade and Local Government
    • 3. Increase awareness of community, private providers and health workers on the counterfeit and substandard of medicines
  • 5. Lessons learned (con’t)
    • 4. Provide adequate training to provincial and district inspectors on technical issues how to do inspections
    • 5. Improvement of rational use of drugs among health staff, providers and consumers
    • 6. Provide necessary equipment, tools and human resources to DRA at each level
  • Thank you